🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 03/06/1985 | 0,0212 USD |
| 28/02/1985 | 0,0212 USD |
| 03/12/1984 | 0,0212 USD |
| 31/08/1984 | 0,0199 USD |
| 29/05/1984 | 0,0199 USD |
| 01/03/1984 | 0,0199 USD |
| 29/11/1983 | 0,0199 USD |
| 29/08/1983 | 0,0186 USD |
| 31/05/1983 | 0,0186 USD |
| 28/02/1983 | 0,0186 USD |
| 30/11/1982 | 0,0186 USD |
| 30/08/1982 | 0,0186 USD |
| 01/06/1982 | 0,0186 USD |
| 01/03/1982 | 0,0186 USD |
| 01/12/1981 | 0,0186 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 21/01/1991 | 13,92 | 14,03 | 13,88 | 13,94 | -0,99% | 1,14% | 2.827.714 |
| 18/01/1991 | 13,98 | 14,09 | 13,88 | 14,07 | +0,71% | 1,56% | 13.416.077 |
| 17/01/1991 | 13,90 | 13,99 | 13,76 | 13,98 | +3,69% | 1,72% | 9.220.723 |
| 16/01/1991 | 13,30 | 13,54 | 13,28 | 13,48 | +1,50% | 1,94% | 3.125.136 |
| 15/01/1991 | 13,20 | 13,36 | 13,18 | 13,28 | +0,75% | 1,36% | 3.221.342 |
| 14/01/1991 | 13,04 | 13,24 | 13,04 | 13,18 | -0,90% | 1,52% | 5.407.680 |
| 11/01/1991 | 13,16 | 13,30 | 13,08 | 13,30 | +0,30% | 1,66% | 3.497.386 |
| 10/01/1991 | 13,18 | 13,26 | 13,14 | 13,26 | +1,37% | 0,91% | 3.509.962 |
| 09/01/1991 | 13,36 | 13,56 | 13,08 | 13,08 | -1,20% | 3,57% | 6.651.446 |
| 08/01/1991 | 13,26 | 13,32 | 13,16 | 13,24 | +0,30% | 1,20% | 6.409.358 |
| 07/01/1991 | 13,36 | 13,50 | 13,18 | 13,20 | -2,64% | 2,38% | 6.252.787 |
| 04/01/1991 | 13,68 | 13,72 | 13,46 | 13,56 | -1,59% | 1,89% | 7.219.882 |
| 03/01/1991 | 14,23 | 14,23 | 13,78 | 13,78 | -3,21% | 3,21% | 4.641.173 |
| 02/01/1991 | 14,19 | 14,29 | 14,17 | 14,23 | -0,42% | 0,84% | 5.369.323 |
| 31/12/1990 | 14,11 | 14,29 | 14,09 | 14,29 | +1,41% | 1,41% | 1.710.336 |
| 28/12/1990 | 13,99 | 14,11 | 13,94 | 14,09 | +0,57% | 1,28% | 1.728.571 |
| 27/12/1990 | 14,07 | 14,11 | 13,99 | 14,01 | -0,28% | 0,85% | 1.769.443 |
| 26/12/1990 | 13,84 | 14,07 | 13,80 | 14,05 | +1,43% | 2,01% | 1.639.282 |
| 24/12/1990 | 13,94 | 13,94 | 13,80 | 13,86 | -0,57% | 1,00% | 1.306.646 |
| 21/12/1990 | 13,84 | 13,99 | 13,82 | 13,94 | +1,74% | 1,29% | 10.863.149 |
| 20/12/1990 | 13,56 | 13,74 | 13,56 | 13,70 | -0,15% | 1,32% | 3.604.282 |
| 19/12/1990 | 13,74 | 13,80 | 13,68 | 13,72 | -0,86% | 0,87% | 3.513.734 |
| 18/12/1990 | 13,68 | 13,90 | 13,68 | 13,84 | +0,87% | 1,60% | 5.115.917 |
| 17/12/1990 | 13,72 | 13,76 | 13,66 | 13,72 | -0,43% | 0,72% | 2.093.275 |
| 14/12/1990 | 13,99 | 13,99 | 13,74 | 13,78 | -1,70% | 1,85% | 3.487.325 |
| 13/12/1990 | 14,07 | 14,11 | 13,96 | 14,01 | -0,42% | 1,13% | 3.034.589 |
| 12/12/1990 | 13,80 | 14,07 | 13,80 | 14,07 | +2,61% | 2,02% | 4.708.454 |
| 11/12/1990 | 13,78 | 13,80 | 13,54 | 13,72 | -0,43% | 1,88% | 4.406.002 |
| 10/12/1990 | 13,74 | 13,84 | 13,70 | 13,78 | +0,00% | 1,01% | 2.694.408 |
| 07/12/1990 | 13,84 | 13,94 | 13,78 | 13,78 | -0,43% | 1,15% | 3.914.280 |